Quality Focus: First, Do No Harm: Adverse Drug Events
Schroeder, S.D.
South Dakota Medicine the Journal of the South Dakota State Medical Association 69(12): 565
2016
ISSN/ISBN: 0038-3317 PMID: 28810110 Document Number: 689326
Document emailed within 1 workday
Related Documents
Homma, M. 1992: Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event Ryumachi 32(5): 429-431Mikkelsen, Tørn.Hougaard.; Rubak, J.M.; Olesen, F. 2004: General practitioners' attitudes toward reporting and learning from adverse events. Experiences from focus group interviews Ugeskrift for Laeger 166(19): 1766-1769
Bhatt, A.D. 1999: Drug-related problems and adverse drug events: negligence, litigation and prevention Journal of the Association of Physicians of India 47(7): 715-720
Merlin, Béatrice.; Chazard, E.; Pereira, S.; Serrot, E.; Sakji, S.; Beuscart, Régis.; Darmoni, S. 2010: Can F-MTI semantic-mined drug codes be used for adverse drug events detection when no CPOE is available? Studies in Health Technology and Informatics 160(Pt 2): 1025-1029
Bezruchka, S. 2001: Adverse events in British hospitals. Expanded definition of adverse events is needed Bmj 322(7299): 1427
Anderson, J.G. 2003: A systems approach to preventing adverse drug events Studies in Health Technology and Informatics 92: 95-102
Sánchez Muñoz, L.A.; Castiella Herrero, J.; Sanjuán Portugal, F.J.; Naya Manchado, J.; Alfaro Alfaro, M.J. 2007: Usefulness of MBDS in detection of adverse drug events Anales de Medicina Interna 24(3): 113-119
Hassan, Y.; Al-Ramahi, R.J.; Aziz, N.A.; Ghazali, R. 2010: Adverse drug events in hospitalized patients with chronic kidney disease International Journal of Clinical Pharmacology and Therapeutics 48(9): 571-576
Parès, Y.; Declerck, G.; Hussain, S.; Ng, R.; Jaulent, M-Christine. 2013: Building a time-saving and adaptable tool to report adverse drug events Studies in Health Technology and Informatics 192: 903-907
Huber, M.; Stahlmann, R. 2012: The eye as target of adverse ocular drug reactions. Focus on systemic antiinfective therapy Medizinische Monatsschrift für Pharmazeuten 35(12): 436
Kohler, P.K.; Namate, D.; Barnhart, S.; Chimbwandira, F.; Tippet-Barr, B.A.; Perdue, T.; Chilongozi, D.A.; Tenthani, L.; Phiri, O.; Msungama, W.; Holmes, K.K.; Krieger, J.N. 2016: Classification and rates of adverse events in a Malawi male circumcision program: impact of quality improvement training Bmc Health Services Research 16: 61
Menter, A.; Reich, K.; Gottlieb, A.B.; Bala, M.; Li, S.; Hsu, M-Chun.; Guzzo, C.; Diels, J.; Gelfand, J.M. 2008: Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations Journal of Drugs in Dermatology: Jdd 7(12): 1137-1146
Minzi, O.M.S.; Irunde, H.; Moshiro, C. 2009: HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania Tanzania Journal of Health Research 11(1): 5-10
Fiore, A.Patricia.Perez.; Fragoso, Y.Dadalti. 2005: Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months Arquivos de Neuro-Psiquiatria 63(3b): 738-740
Lassere, M.N.D.; Johnson, K.R.; Boers, M.; Carlton, K.; Day, R.O.; de Wit, M.; Edwards, I.Ralph.; Fries, J.F.; Furst, D.E.; Kirwan, J.R.; Tugwell, P.S.; Woodworth, T.G.; Brooks, P.M. 2005: Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update Journal of Rheumatology 32(10): 2037-2041
Centonze, V.; Bassi, A.; Causarano, V.; Dalfino, L.; Cassiano, M.A.; Centonze, A.; Fabbri, L.; Albano, O. 2000: Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis Functional Neurology 15(3): 167-170
Chazard, E.; Ficheur, Gégoire.; Merlin, Béatrice.; Serrot, E.; Beuscart, Régis. 2009: Adverse drug events prevention rules: multi-site evaluation of rules from various sources Studies in Health Technology and Informatics 148: 102-111
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Wang, D.; Du, X-Xi. 2012: Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688
Okada, K. 2011: Adverse events following vaccination Nihon Rinsho. Japanese Journal of Clinical Medicine 69(9): 1639-1643